Abbott Diabetes Care, Inc. recalls FreeStyle Libre 3 App
FDA Class II
FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.
- Hazard
- If using affected glucose monitoring app on Android 13 Operating System, extended periods of signal loss may be experienced, due to app not connected, which could impact ability to receive glucose reading/alarms, which could lead to undetected low or high glucose, which could result in delayed treatment: not taking insulin (for high glucose), or not taking glucose (for low glucose) when required.
- Products
-
- FreeStyle Libre 3 App
- Company
- Abbott Diabetes Care, Inc.
- Where it was sold
-
US Nationwide distribution in the states of NY, CA, NJ, UT, PA, MS, OH, TX, MN, FL, LA, NE, MI, VA, NC, MA, IN, SC, IA.
States: California, Florida, Iowa, Indiana, Louisiana, Massachusetts, Michigan, Minnesota, Mississippi, North Carolina, Nebraska, New Jersey, New York, Ohio, Pennsylvania, South Carolina, Texas, Utah, Virginia
- Barcodes
00357599816001- Units affected
- 45,173
- About this recall
- FreeStyle Libre 3 App, part of Continuous Glucose Monitoring System, when used on the Android 13 Operating System